India  

'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'

IndiaTimes Monday, 4 January 2021
Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being "targeted by everyone in the world" for being an Indian company's product.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: 'Indian companies don't deserve backlash': Bharat Biotech MD on clinical trials

'Indian companies don't deserve backlash': Bharat Biotech MD on clinical trials 01:29

While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna Ella said, "Many people just gossiping, it's just a backlash against Indian companies. That is not right for us. We don't...

💡 newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield

An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a..
IndiaTimes

Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin doses

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
IndiaTimes

After suspending Covaxin clinical trials, Brazil closes EUA request

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
IndiaTimes

COVID-19 vaccine for children likely by September: AIIMS Chief

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
DNA

You Might Like


Related videos from verified sources

"Covaxin is successful in tackling UK strain," informs ICMR [Video]

"Covaxin is successful in tackling UK strain," informs ICMR

Indian Council of Medical Research DG, Balram Bhargava announced that the Covaxin is successful in tackling UK strain. He further informed that UK variant strain is now present in 70 countries and 164..

Credit: ANI     Duration: 01:55Published
TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get..

Credit: ANI     Duration: 01:28Published
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based..

Credit: ANI     Duration: 01:30Published

Related news from verified sources

Covaxin generated excellent safety data, says Bharat Biotech

Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat...
Mid-Day

What you need to know about Oxford COVID-19 vaccine

With the UK giving the green light to the Covid-19 vaccine developed by Oxford University and drug maker AstraZeneca, India is also expected to follow suit soon...
Mid-Day

Won't get COVID-19 vaccine as BJP govt cannot be trusted: Akhilesh Yadav

Amid the dry run of coronavirus vaccine taking place in the country, Samajwadi Party (SP) chief Akhilesh Yadav on Saturday said that he will not get vaccinated...
Mid-Day Also reported by •IndiaTimes